Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GABRP | O00591 | 1/20 | 0.34 |
| ▸ | GABRD | O14764 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | TNKS | O95271 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18372144 | 0.84 | PLA2G2A (0.39) | HPGDMAPTSMN1; SMN2KDM4ENPC1 | |
| SCHEMBL18372079 | 0.81 | NQO2 (0.36) | HPGDMAPTKDM4EALDH1A1MEN1 | |
| SCHEMBL18372118 | 0.80 | NPSR1 (0.36) | MAPTLMNAHTT | |
| SCHEMBL18372103 | 0.80 | NPSR1 (0.41) | HPGDMAPTSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL18372140 | 0.80 | ESR1 (0.34) | HPGDALDH1A1ABCG2AHRHSD17B10 | |
| SCHEMBL20746673 | 0.79 | NPSR1 (0.38) | MEN1KMT2ALMNA | |
| SCHEMBL18372109 | 0.79 | ESR1 (0.33) | HPGDALDH1A1ABCG2AHRHSD17B10 | |
| SCHEMBL18372116 | 0.79 | KDM4E (0.39) | HPGDMAPTSMN1; SMN2KDM4ENPC1 | |
| SCHEMBL18372139 | 0.78 | CYP1A2 (0.34) | HPGDMAPTSMN1; SMN2KDM4ERAB9A | |
| SCHEMBL18253876 | 0.77 | KDM4E (0.35) | HPGDMAPTSMN1; SMN2KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10211404-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-02-19 | — | — | US | disclosed |
| US-20170012209-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-12 | — | — | US | disclosed |
| US-20170012209-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170012209-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | PIEZO1, TERT, TPR | HPGD 3410/4885MAPT 1255/4885SMN1; SMN2 3172/4885 |
| US-10211404-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device | PIEZO1, TERT, TPR | HPGD 3410/4885MAPT 1255/4885SMN1; SMN2 3172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.